3 Reasons Why Growth Investors Shouldn’t Overlook Horizon Therapeutics (HZNP) Posted byZacks Equity Research October 19, 2021 Leave a comment on 3 Reasons Why Growth Investors Shouldn’t Overlook Horizon Therapeutics (HZNP) Horizon Therapeutics (HZNP) possesses solid growth attributes, which could help it handily outperform the market.